These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19900544)

  • 61. Nanosponges - a completely new nano-horizon: pharmaceutical applications and recent advances.
    Ahmed RZ; Patil G; Zaheer Z
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1263-72. PubMed ID: 22681585
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Equilibrium kinetics of the new experimental anti-tumour compound SK&F 104864-A in aqueous solution.
    Underberg WJ; Goossen RM; Smith BR; Beijnen JH
    J Pharm Biomed Anal; 1990; 8(8-12):681-3. PubMed ID: 2100606
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers.
    Barreiro-Iglesias R; Bromberg L; Temchenko M; Hatton TA; Concheiro A; Alvarez-Lorenzo C
    J Control Release; 2004 Jul; 97(3):537-49. PubMed ID: 15212885
    [TBL] [Abstract][Full Text] [Related]  

  • 64. First evaluation of drug-in-cyclodextrin-in-liposomes as an encapsulating system for nerolidol.
    Azzi J; Auezova L; Danjou PE; Fourmentin S; Greige-Gerges H
    Food Chem; 2018 Jul; 255():399-404. PubMed ID: 29571492
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nanomicelle with long-term circulation and enhanced stability of camptothecin based on mPEGylated alpha,beta-poly (L-aspartic acid)-camptothecin conjugate.
    Zhang W; Huang J; Fan N; Yu J; Liu Y; Liu S; Wang D; Li Y
    Colloids Surf B Biointerfaces; 2010 Nov; 81(1):297-303. PubMed ID: 20674289
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nanosponges-based Drug Delivery System for the Cosmeceutical Applications of Stabilized Ascorbic Acid.
    Zuberi SA; Sheraz MA; Ali SA; Shah MR; Mujahid S; Ahmed S; Anwar Z
    Curr Drug Deliv; 2023; 20(10):1504-1524. PubMed ID: 35975853
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions.
    Zhao YX; Hua HY; Chang M; Liu WJ; Zhao Y; Liu HM
    Int J Pharm; 2010 Jun; 392(1-2):64-71. PubMed ID: 20302926
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
    Koo OM; Rubinstein I; Onyuksel H
    Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of Crystalline Cellulosic Fibres for Sustained Release of Drug.
    Mishra D; Yadav V; Khare P; Jyotshna ; Das MR; Meena A; Shanker K
    Curr Top Med Chem; 2016; 16(18):2026-35. PubMed ID: 26876520
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preparation and antitumor study of camptothecin nanocrystals.
    Zhang H; Hollis CP; Zhang Q; Li T
    Int J Pharm; 2011 Aug; 415(1-2):293-300. PubMed ID: 21679755
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inclusion complex of GA-13315 with cyclodextrins: preparation, characterization, inclusion mode and properties.
    Yang R; Chen JB; Dai XY; Huang R; Xiao CF; Gao ZY; Yang B; Yang LJ; Yan SJ; Hong-Bin Zhang ; Qing C; Lin J
    Carbohydr Polym; 2012 Jun; 89(1):89-97. PubMed ID: 24750608
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Incorporation of camptothecin into reduction-degradable supramolecular micelles for enhancing its stability.
    Luo P; Luo Y; Huang J; Lu W; Luo D; Yu J; Liu S
    Colloids Surf B Biointerfaces; 2013 Sep; 109():167-75. PubMed ID: 23643912
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin.
    Whitaker RD; Ingebrigtsen SG; Naderkhani E; Skar ML; Flaten GE
    J Liposome Res; 2013 Dec; 23(4):298-310. PubMed ID: 23763495
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Melarsoprol-cyclodextrins inclusion complexes.
    Gibaud S; Zirar SB; Mutzenhardt P; Fries I; Astier A
    Int J Pharm; 2005 Dec; 306(1-2):107-21. PubMed ID: 16253447
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Exploring Cyclodextrin-Based Nanosponges as Drug Delivery Systems: Understanding the Physicochemical Factors Influencing Drug Loading and Release Kinetics.
    Pyrak B; Rogacka-Pyrak K; Gubica T; Szeleszczuk Ł
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542499
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin.
    Tang XJ; Han M; Yang B; Shen YQ; He ZG; Xu DH; Gao JQ
    Int J Pharm; 2014 Dec; 477(1-2):536-45. PubMed ID: 25445532
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium.
    Ungaro F; Giovino C; Catanzano O; Miro A; Mele A; Quaglia F; La Rotonda MI
    Int J Pharm; 2011 Feb; 404(1-2):49-56. PubMed ID: 21056648
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of alkylcarbonates of gamma-cyclodextrins with different chain lengths on drug complexation and release characteristics.
    Cavalli R; Trotta F; Trotta M; Pastero L; Aquilano D
    Int J Pharm; 2007 Jul; 339(1-2):197-204. PubMed ID: 17418510
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Measurement of NLG207 (formerly CRLX101) nanoparticle-bound and released camptothecin in human plasma.
    Schmidt KT; Peer CJ; Huitema ADR; Williams MD; Wroblewski S; Schellens JHM; Madan RA; Figg WD
    J Pharm Biomed Anal; 2020 Mar; 181():113073. PubMed ID: 31927166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.